Literature DB >> 1656193

Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatases.

R E Honkanen1, M Dukelow, J Zwiller, R E Moore, B S Khatra, A L Boynton.   

Abstract

The present study characterizes the inhibitory effects of nodularin, a recently isolated hepatotoxic compound from the cyanobacterium Nodularia spumigena, on type 1 (PP1), type 2A, (PP2A), type 2B (PP2B), and type 2C (PP2C) protein phosphatases. Both PP2A and PP1 were potently inhibited (IC50 = 0.026 and 1.8 nM, respectively) by nodularin, whereas PP2B was inhibited to a lesser extent (IC50 = 8.7 microM). Nodularin had no apparent effect on PP2C, alkaline phosphatase, acid phosphatase, insulin receptor tyrosine kinase, protein kinase A, phosphorylase kinase, or protein kinase C. In a whole-cell extract of T51B liver cells, nodularin inhibited PP1 and PP2A activity with a potency similar to that seen with their purified catalytic subunits. Thus, due to the high specificity of nodularin for PP2A and PP1, this hepatotoxin may prove to be useful as a probe for distinguishing the activity of these protein phosphatases in cell extracts.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656193

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  27 in total

1.  Cyanobacteria produce a high variety of hepatotoxic peptides in lichen symbiosis.

Authors:  Ulla Kaasalainen; David P Fewer; Jouni Jokela; Matti Wahlsten; Kaarina Sivonen; Jouko Rikkinen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

Review 2.  Health Effects of Toxic Cyanobacteria in U.S. Drinking and Recreational Waters: Our Current Understanding and Proposed Direction.

Authors:  Timothy G Otten; Hans W Paerl
Journal:  Curr Environ Health Rep       Date:  2015-03

3.  The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C.

Authors:  Brandon M D'Arcy; Mark R Swingle; Cinta M Papke; Kevin A Abney; Erin S Bouska; Aishwarya Prakash; Richard E Honkanen
Journal:  Mol Cancer Ther       Date:  2019-01-24       Impact factor: 6.261

4.  Bioengineered protein phosphatase 2A: update on need.

Authors:  Juan A Rubiolo; Henar López-Alonso; Amparo Alfonso; Félix V Vega; Mercedes Rodríguez Vieytes; Luis M Botana
Journal:  Bioengineered       Date:  2012-10-23       Impact factor: 3.269

5.  Opposite regulation of inhibitory synaptic plasticity by α and β subunits of Ca(2+)/calmodulin-dependent protein kinase II.

Authors:  Nobuhiro Nagasaki; Tomoo Hirano; Shin-ya Kawaguchi
Journal:  J Physiol       Date:  2014-09-12       Impact factor: 5.182

6.  Variation of Microcystis and microcystins coupling nitrogen and phosphorus nutrients in Lake Erhai, a drinking-water source in Southwest Plateau, China.

Authors:  Gongliang Yu; Yongguang Jiang; Gaofei Song; Wenhua Tan; Mengling Zhu; Renhui Li
Journal:  Environ Sci Pollut Res Int       Date:  2014-05-02       Impact factor: 4.223

7.  Nodularin, a cyanobacterial toxin, is synthesized in planta by symbiotic Nostoc sp.

Authors:  Michelle M Gehringer; Lewis Adler; Alexandra A Roberts; Michelle C Moffitt; Troco K Mihali; Toby J T Mills; Claus Fieker; Brett A Neilan
Journal:  ISME J       Date:  2012-03-29       Impact factor: 10.302

8.  Crystal structures of protein phosphatase-1 bound to nodularin-R and tautomycin: a novel scaffold for structure-based drug design of serine/threonine phosphatase inhibitors.

Authors:  Matthew S Kelker; Rebecca Page; Wolfgang Peti
Journal:  J Mol Biol       Date:  2008-11-01       Impact factor: 5.469

Review 9.  Effects of marine toxins on the reproduction and early stages development of aquatic organisms.

Authors:  Vítor Vasconcelos; Joana Azevedo; Marisa Silva; Vítor Ramos
Journal:  Mar Drugs       Date:  2010-01-19       Impact factor: 5.118

Review 10.  On the chemistry, toxicology and genetics of the cyanobacterial toxins, microcystin, nodularin, saxitoxin and cylindrospermopsin.

Authors:  Leanne Pearson; Troco Mihali; Michelle Moffitt; Ralf Kellmann; Brett Neilan
Journal:  Mar Drugs       Date:  2010-05-10       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.